Le Lézard
Classified in: Health
Subjects: WOM, CFG, MIN, DEI

Removing barriers for sperm and ova donors


OTTAWA, ON, May 8, 2024 /CNW/ - Many people including those experiencing infertility, single parents and same-sex couples, may choose assisted human reproduction, including the use of donated sperm and ova, as a way of growing their families.

Today, the Honourable Mark Holland, Minister of Health, is announcing that Health Canada's updated screening criteria for sperm and ova donors have come into force, integrating the latest scientific evidence and input from consultations with subject-matter experts in donor screening, industry, patient associations, and 2SLGBTQIA+ groups.

In 2022, Health Canada approved submissions from Canada's two blood operators, Canadian Blood Services and Héma-Québec, to eliminate the blood donor deferral period for men who have sex with men (MSM) and other individuals affected by the previous deferral policies. Today's announcement builds on that progress and is a step forward in reducing barriers that prevented many individuals from donating sperm. The Government of Canada is committed to ensuring that its sperm and ova donation policy is safe, inclusive and scientifically based.

Health Canada is working with the Canadian Standards Association to discuss potential changes to the MSM donor screening criteria for cells, tissues and organs (CTOs), that are under current consideration by experts in the field of CTO donation. The Government of Canada is working toward a more inclusive donation system that is supported by the recent advancements in scientific evidence.

Quotes

"Our government is committed to continuing safe, inclusive, and scientifically-based sperm and ova donation policies. By following the latest evidence and science, we are ensuring that the sperm and ova supply is stable to allow all Canadians to grow their families."

The Honourable Mark Holland 
Minister of Health

Associated Links

SOURCE Health Canada (HC)


These press releases may also interest you

at 18:00
bioLytical Laboratories Inc. announced today the immediate availability of its INSTI® HCV Antibody Test in the Australian market.  The INSTI Hepatitis C (HCV) Antibody Test is now included in the Australian Register of Therapeutic Goods (ARTG...

at 17:20
The Phase IIa COURSE trial was a proof-of-concept study in people with moderate to very severe chronic obstructive pulmonary disease (COPD) with a broad range of blood eosinophil counts (BEC) and irrespective of emphysema, chronic bronchitis or...

at 14:15
Endeavor BioMedicines, a clinical-stage biotechnology company developing medicines with the potential to deliver transformational clinical benefits to patients with life-threatening diseases, announced results from a completed Phase 2a clinical trial...

at 12:20
Savara Inc. (the Company), a clinical stage biopharmaceutical company focused on rare respiratory diseases, presented a poster at the American Thoracic Society (ATS) 2024 International Conference that is taking place May 17-22, 2024, in San Diego,...

at 12:18
Product: Kalihim (Philippine Bread Roll) Issue: Food - Allergen - Egg Distribution: British Columbia See the affected products and product photos for this recall SOURCE Canadian Food Inspection Agency (CFIA)

at 11:10
Orion Health, a global leader in digital health solutions, announced today that it has been awarded partner status by Panda Health for its Orchestral Health Intelligence Platform, one of three pillars of the Unified Healthcare Platform. Panda Health...



News published on and distributed by: